Chimeron Bio
Developer of self-amplifying therapeutics and vaccines intended to offer gene therapies and personalized medicines to patients. The company's platform leverages chimera-encased self-amplifying RNA to ...
Valuation
$0
Share Price
N/A
Total Raised
$18.1M
Last Round
N/A